Journal of the American Society of Nephrology· 2017Q1
Cell-Free DNA and Active Rejection in Kidney Allografts
- 576citations
- Q1SCImago
- 2017year
Short summary
Donor-derived cell-free DNA (dd-cfDNA) in blood can noninvasively differentiate kidney transplant rejection from other injuries, with levels above 1.0% indicating a probability of active rejection.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Transplantation
TransplantationMedicine